Precision Medicine

PSA Screening Prostate Cancer Evidence Review

George Padron
Oncology Care, Biomarker & Genomic Testing, GU Cancers | Jun 20, 2026
An updated Cochrane review of almost 800,000 men finds PSA screening likely reduces prostate cancer deaths, about one per 500 invited, set against overdiagnosis risk.

Consumer Genomics Seeks to Link Genetic Information with Medical Records

George Padron
Precision Medicine, Biomarker & Genomic Testing, Healthcare Headlines | May 19, 2026
23andMe partners with HealthEx to integrate genetic data with medical records and lifestyle inputs, offering an AI-written health summary to 30,000 beta users.

Beyond Headache Days: Migraine's Cognitive Toll Gets Closer Examination

George Padron
Precision Medicine, Specialty Medicine, Neurology & CNS Disorders | Apr 23, 2026
Real-world INFUSE study data at AAN 2026 show eptinezumab improves migraine-related cognitive symptoms in over 50% of patients with prior anti-CGRP failure at 6 months.

First Brain-Penetrating Enzyme Therapy Wins FDA Approval for Hunter Syndrome

Sonia Reyes
Precision Medicine, Specialty Medicine, Policy & Legislation | Apr 4, 2026
Denali's Avlayah wins accelerated FDA approval as the first brain-penetrating enzyme replacement therapy for Hunter syndrome's cognitive decline.

The Oversight Gap in America's Organ Procurement System

Sonia Reyes
Precision Medicine, Transplant Diagnostics | Mar 24, 2026
Congressional hearings and a major OPTN restructuring aim to address consent verification failures and accountability gaps in organ procurement oversight.